Actionable news
0
All posts from Actionable news
Actionable news in AGN: ALLERGAN Inc,

Allergan plc (NYSE:AGN) Attains Rights To CONSTELLA in EU- Symantec Corporation (NASDAQ:SYMC), The Goldman Sachs Group, Inc. (NYSE:GS)

Allergan plc (NYSE:AGN) jumped up 6.13% to end at $268.55 following starting the session at $271.04. Allergan plc (AGN) and Ironwood Pharmaceuticals, Inc. (IRWD) reported that Allergan has attained rights to CONSTELLA (linaclotide) in the Eu, Switzerland, Turkey and the Ordinarywealth of Independent States from Almirall, S.A. Allergan attaind an exclusive license for CONSTELLA in these countries. Allergan plc has also reattaind rights to LINZESS (linaclotide) in Mexico from Almirall. CONSTELLA is presently agreed by the European Commission for the symptomatic treatment of moderate-to-severe irritable bowel syndrome with constipation in adults. Force behind Allergan plc bullish run in this report? Read Full Report Here

Separately, some of the notable components of this sector, which showed robust stock movement included: Symantec Corporation (NASDAQ:SYMC), The Goldman Sachs Group, Inc. (NYSE:GS)

Symantec Corporation (NASDAQ:SYMC) jumps up...


More